Musashi-2 (MSI2) and its homolog, MSI1, are emerging as regulators of multiple critical biological processes relevant to cancer initiation, progression, stem cell compartment maintenance, and drug resistance, which are upregulated in many hematopoietic and solid tumors, including lung6–8. The gene discussed is MSI2; the disease is cancer.